Cargando…
Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is among the most aggressive human malignancies with an overall 5-year survival rate of <5%. Despite significant advances in treatment of the disease during the past decade, the median survival rate (∼6 months) has hardly improved, warranting th...
Autores principales: | Kaistha, B P, Honstein, T, Müller, V, Bielak, S, Sauer, M, Kreider, R, Fassan, M, Scarpa, A, Schmees, C, Volkmer, H, Gress, T M, Buchholz, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453723/ https://www.ncbi.nlm.nih.gov/pubmed/25137017 http://dx.doi.org/10.1038/bjc.2014.460 |
Ejemplares similares
-
Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection
por: Nunes, J, et al.
Publicado: (2012) -
A Multistep High-Content Screening Approach to Identify Novel Functionally Relevant Target Genes in Pancreatic Cancer
por: Buchholz, Malte, et al.
Publicado: (2015) -
Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma
por: Wang, Jia, et al.
Publicado: (2017) -
Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer
por: Milde-Langosch, K, et al.
Publicado: (2005) -
Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer
por: Kuefer, R, et al.
Publicado: (2005)